SIVA ARUNASALAM
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease VICTORVILLE, CA NPI 1609806041
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease CA ShockWave Medical, Inc All categories
General Payments — all program years on this page
$44,830.55
- Category: General Payments
- Program years: PY2018–2024
- Record count: 650
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,454.11 across 82 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,443.26 | 81 |
| Education | $10.85 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ShockWave Medical, Inc | $1,526.51 | 13 |
| Merck Sharp & Dohme Corporation | $401.50 | 18 |
| Medtronic, Inc. | $304.66 | 6 |
| HEARTFLOW, INC. | $211.67 | 5 |
| SCPHARMACEUTICALS INC. | $146.16 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $113.72 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $101.81 | 6 |
| PFIZER INC. | $85.16 | 3 |
| BAXTER HEALTHCARE | $70.30 | 3 |
| BIOTRONIK INC. | $60.00 | 1 |
| Edwards Lifesciences Corporation | $57.46 | 2 |
| Novo Nordisk AS | $54.75 | 3 |
| Abbott Laboratories | $41.48 | 2 |
| Kestra Medical Technology Services, Inc. | $38.53 | 2 |
| E.R. Squibb & Sons, L.L.C. | $38.41 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $36.76 | 2 |
| Actelion Pharmaceuticals US, Inc. | $36.45 | 2 |
| SANOFI-AVENTIS U.S. LLC | $19.98 | 1 |
| ABBVIE INC. | $17.00 | 1 |
| VIVUS LLC | $16.19 | 1 |
| Janssen Pharmaceuticals, Inc | $16.18 | 1 |
| Philips Electronics North America Corporation | $15.64 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.34 | 1 |
| Acerta Pharma LLC | $14.58 | 1 |
| Kiniksa Pharmaceuticals International, plc | $13.87 | 1 |
By program year
Records — PY2024 (82)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.